Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, Specialty Medicines
GSK
August 19, 2026
Remote friendly (London, England, United Kingdom)
United States
Clinical Research and Development
Responsibilities:
- Provide leadership, management, and development of a Data Generation book of work.
- Partner with matrix stakeholders to plan and design data generation plans (DGP), drive disciplined study execution, translate results, and disseminate findings internally and externally.
- Provide scientific leadership for real-world evidence and non-interventional study methodologies, including enabling external scientific advice and incorporating protocol review committee guidance.
- Engage external experts, clinical guideline groups, HTA agencies, and methodology/policy forums to drive innovation and enable efficient evidence development across the lifecycle.
- Integrate expertise in global HTA bodies, clinical guidelines, payer decision makers, and processes related to recommendation, reimbursement, pricing, and access.
- Lead discussions to prioritize data generation based on business and customer needs.
- Deliver materials for internal governance (e.g., Medical Review Board).
- Facilitate alignment across complex stakeholder matrices (clinical, commercial, market access, medical affairs, priority market LOCs, and external suppliers).
- Represent the company in external collaborations and evidence requirements with partners and decision makers.
- Drive quality and compliance of delivered evidence; ensure performance reporting, studies are delivered on plan and within budget.
Qualifications (Required):
- PhD, PharmD, or equivalent in health outcomes/PROs, health economics, epidemiology, pharmacy, health, or life sciences.
- 5+ years in global pharmaceuticals in a leadership role with line management experience.
- Strong business acumen; ability to translate customer needs into actionable data generation plans.
- Methods expertise for robust payer evidence deliverables and credibility with external experts.
- Knowledge of global and local healthcare markets, HTA, and reimbursement decision-making.
- Understanding of health economics/outcomes, comparative effectiveness, PRO research, and PRO instruments for local decision-making.
- Deep knowledge of drug development and therapy area.
- Strong communication, matrix leadership, and stakeholder management; ability to work independently.
- Experience across product lifecycles; senior experience leading a complex portfolio and analytics staff.
Qualifications (Preferred):
- Advanced degree specialized in health outcomes.
- Experience in above-country and in-country roles.
- Hepatology therapeutic area experience.
- Experience supporting assets in complex competitor landscapes.
- Direct payer experience.
- Launch experience.
- Portfolio of high value publications and/or scientific promotions.
- Provide leadership, management, and development of a Data Generation book of work.
- Partner with matrix stakeholders to plan and design data generation plans (DGP), drive disciplined study execution, translate results, and disseminate findings internally and externally.
- Provide scientific leadership for real-world evidence and non-interventional study methodologies, including enabling external scientific advice and incorporating protocol review committee guidance.
- Engage external experts, clinical guideline groups, HTA agencies, and methodology/policy forums to drive innovation and enable efficient evidence development across the lifecycle.
- Integrate expertise in global HTA bodies, clinical guidelines, payer decision makers, and processes related to recommendation, reimbursement, pricing, and access.
- Lead discussions to prioritize data generation based on business and customer needs.
- Deliver materials for internal governance (e.g., Medical Review Board).
- Facilitate alignment across complex stakeholder matrices (clinical, commercial, market access, medical affairs, priority market LOCs, and external suppliers).
- Represent the company in external collaborations and evidence requirements with partners and decision makers.
- Drive quality and compliance of delivered evidence; ensure performance reporting, studies are delivered on plan and within budget.
Qualifications (Required):
- PhD, PharmD, or equivalent in health outcomes/PROs, health economics, epidemiology, pharmacy, health, or life sciences.
- 5+ years in global pharmaceuticals in a leadership role with line management experience.
- Strong business acumen; ability to translate customer needs into actionable data generation plans.
- Methods expertise for robust payer evidence deliverables and credibility with external experts.
- Knowledge of global and local healthcare markets, HTA, and reimbursement decision-making.
- Understanding of health economics/outcomes, comparative effectiveness, PRO research, and PRO instruments for local decision-making.
- Deep knowledge of drug development and therapy area.
- Strong communication, matrix leadership, and stakeholder management; ability to work independently.
- Experience across product lifecycles; senior experience leading a complex portfolio and analytics staff.
Qualifications (Preferred):
- Advanced degree specialized in health outcomes.
- Experience in above-country and in-country roles.
- Hepatology therapeutic area experience.
- Experience supporting assets in complex competitor landscapes.
- Direct payer experience.
- Launch experience.
- Portfolio of high value publications and/or scientific promotions.